Central Line-associated Bloodstream Infection (CLABSI)
16
1
1
10
Key Insights
Highlights
Success Rate
100% trial completion (above average)
Clinical Risk Assessment
Based on trial outcomes
Moderate Risk
Score: 40/100
0.0%
0 terminated out of 16 trials
100.0%
+13.5% vs benchmark
19%
3 trials in Phase 3/4
10%
1 of 10 completed with results
Key Signals
Data Visualizations
Phase Distribution
Trial Status
Trial Success Rate
Benchmark: 86.5%
Based on 10 completed trials
Clinical Trials (16)
Compassionate-Use of 4% T-EDTA Lock Solution for Central Venous Lines of Pediatric PN Patients
Hydrochloric Acid Lock Therapy for Central Line-associated Bloodstream Infections
CLiCK in the Critical Care Unit
Daily Chlorexidine Bath for Health Care Associated Infection Prevention
Determining the Prevalence of Primary and Secondary Central Line Associated Blood Stream Infection (CLABSI) at the Tertiary Care Hospital
Central Venous Catheter Insertion Site and Colonization in Pediatric Cardiac Surgery
The Association Between Chlorhexidine Bathing and Central Line-Associated Infections in Medical Intensive Care Units
Central Line-associated Bloodstream Infection Prevention Using TauroLock-Hep100 in Pediatric Oncology Patients.
Implementation Program to Improve CHG Bathing Compliance
Effect of Vancomycin After Catheter Replacement
Ethanol-lock Therapy for the Prevention of Non-tunneled Catheter-related Infection in Pediatric Patients
Patient Safety Learning Laboratory: Making Acute Care More Patient-Centered
The Effects of Different Ways of Dressing Central Line Associated Bloodstream Infections
Port Protectors for Prevention of CLABSIs in Respiratory Semi-intensive Care Unit
Safe Critical Care: Testing Improvement Strategies
Umbilical Cord Care for the Prevention of Colonization